Hair Changes in Women With Type 2 Diabetes Compared With Healthy Women
Compares hair changes in women with type 2 diabetes against healthy women.
Plain-language title generated from the registry record
Registry title: Hair Changes in Females With Type 2 Diabetes Clinical and Trichoscopic Examination
Key facts
- Where
- Cairo, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 60 years old?
Source: NCT07817277, who can take part
Where in Egypt
- Al Zahraa hospitalCairo, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Al-Azhar University
- Trial code
- NCT07817277
- Record updated
- 14 September 2026
- Original description
The aim of this thesis is to investigate the effect of diabetes mellitus on hair by assessing and comparing clinical and dermoscopic hair changes in diabetic patients versus age and sex-matched healthy controls.Read full original descriptionShow less
Evaluation of Hair Changes in Female Patients With Type2 Diabetes Mellitus Versus Non-Diabetic Controls :A Clinical and Dermoscopic Cross-Sectional Study
The aim of this thesis is to investigate the effect of diabetes mellitus on hair by assessing and comparing clinical and dermoscopic hair changes in diabetic patients versus age and sex-matched healthy controls.
Inclusion: Cases:; Female patients aged 20-60 years; Diagnosed with type 2 diabetes mellitus for at least 1 year; HbA1c ≥ 6.5% o Consent to participate; Controls:; Age-matched healthy females (no history of diabetes or insulin resistance); Normal fasting blood sugar (<100 mg/dL) and HbA1c (<5.7%) o No known chronic illness; Consent to participate.
Exclusion: Current pregnancy or lactation; Thyroid dysfunction • Polycystic ovary syndrome (PCOS); Anemia (Hb < 10 g/dL); History of chemotherapy, radiotherapy, or recent acute illness; Scalp diseases (e.g., tinea capitis, scarring alopecia); Recent use of drugs known to affect hair growth (e.g., isotretinoin, spironolactone).